Overexpression of Transferrin Receptor in Esophageal Squamous Cell Cancer Suggests Poor Prognosis and Potential Therapy
Cancer Science · 2026-02 · 117 (2) · 393-406
DOI: 10.1111/cas.70195 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, online erschienen am 11.11.2025. Verfasst von Naoki Ikenaga und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery, The University of Osaka Graduate School of Medicine, Suita, Japan. Hauptthemen laut MEDLINE: Receptors, Transferrin, Esophageal Neoplasms, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Despite recent advancements in multimodal therapies for esophageal squamous cell cancer (ESCC), the prognosis remains poor. Identifying suitable biomarkers for predicting prognosis and exploring new therapeutic targets are essential to improving treatment outcomes in ESCC. In this study, we utilized proteomic technology to identify the transferrin receptor (TfR), the main cellular iron importer, as a novel tumor antigen in ESCC. The clinicopathological characteristics of TfR were evaluated by immunohistochemistry using ESCC specimens, revealing that high TfR expression was associated with poor prognosis. Knockdown of TfR in ESCC cell lines resulted in a decrease in intracellular iron levels and suppressed the proliferation of ESCC cell lines, inducing cell cycle arrest in the G0/G1 phase by inhibiting cyclin D, cyclin E, and cyclin‐dependent kinase 2 . Furthermore, the administration of deferoxamine (DFO), an oral iron chelator, induced a decrease in intracellular iron and suppressed the proliferation of ESCC cell lines and an increase in caspase 3 and 7 activity, indicating the induction of apoptosis. In an ESCC xenograft mouse model, the DFO‐treated group exhibited decreased serum iron levels and reduced tumor size. Finally, we confirmed that the deficiency of iron in ESCC cell lines induced an increase in TfR expression via upregulation of iron regulatory protein 2. These findings suggest that TfR is an independent prognostic factor in ESCC and that targeting iron metabolism may be a promising therapeutic approach for improving ESCC treatment outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterological Surgery, The University of Osaka Graduate School of Medicine, Suita, Japan.
- Institute for Biomedical Sciences Molecular Pathophysiology, Iwate Medical University School of Medicine, Yahaba, Japan.
- Division of Allergy and Rheumatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Yahaba, Japan.
- Department of Pathology, The University of Osaka Graduate School of Medicine, Suita, Japan.
- Division of Fostering Required Medical Human Resources, Center for Infectious Disease Education and Research (CiDER), The University of Osaka, Suita, Japan.
ORCID-Profile: Tsuyoshi Takahashi, Tomoki Makino, Takuro Saito, Hidetoshi Eguchi
Zitieren
APA
Ikenaga, N., Takahashi, T., Tanaka, K., Serada, S., Fujimoto, M., Momose, K., Yamashita, K., Makino, T., Saito, T., Yamamoto, K., Kurokawa, Y., Nakajima, K., Fujii, T., Morii, E., Naka, T., Eguchi, H., & Doki, Y. (2026). Overexpression of Transferrin Receptor in Esophageal Squamous Cell Cancer Suggests Poor Prognosis and Potential Therapy. Cancer Science, 117(2), 393-406. https://doi.org/10.1111/cas.70195
Vancouver
Ikenaga N, Takahashi T, Tanaka K, Serada S, Fujimoto M, Momose K, et al. Overexpression of Transferrin Receptor in Esophageal Squamous Cell Cancer Suggests Poor Prognosis and Potential Therapy. Cancer Science. 2026;117(2):393-406. doi:10.1111/cas.70195
BibTeX
@article{Ikenaga2026,
author = {Ikenaga, Naoki and Takahashi, Tsuyoshi and Tanaka, Koji and Serada, Satoshi and Fujimoto, Minoru and Momose, Kota and Yamashita, Kotaro and Makino, Tomoki and Saito, Takuro and Yamamoto, Kazuyoshi and Kurokawa, Yukinori and Nakajima, Kiyokazu and Fujii, Tomomi and Morii, Eiichi and Naka, Tetsuji and Eguchi, Hidetoshi and Doki, Yuichiro},
title = {Overexpression of Transferrin Receptor in Esophageal Squamous Cell Cancer Suggests Poor Prognosis and Potential Therapy},
journal = {Cancer Science},
year = {2026},
volume = {117},
number = {2},
pages = {393--406},
doi = {10.1111/cas.70195}
}
EUVIMED